Clinical features and outcomes of spitzoid proliferations in children and adolescents
- PMID: 30467833
- PMCID: PMC6531374
- DOI: 10.1111/bjd.17450
Clinical features and outcomes of spitzoid proliferations in children and adolescents
Abstract
Background: Spitzoid proliferations range from Spitz naevi to melanomas. There are few studies describing clinical features and outcomes in the paediatric population.
Objectives: To determine the clinical features and outcomes of a large paediatric cohort with histopathologically confirmed Spitz tumours.
Methods: This was a retrospective cohort study of patients seen at Boston Children's Hospital who were aged < 20 years and had a histopathological diagnosis of spitzoid proliferation from 1 January 1994 to 23 October 2012.
Results: In total 595 patients with 622 spitzoid proliferations were identified (median age 7·4 years, interquartile range 4·6-11·7). Overall 512 proliferations (82·3%) were typical, 107 (17·2.%) were atypical and three (0·5%) were melanomas. The median ages at biopsy were 7·4, 7·2 and 17·2 years, respectively, and there was a significant difference in age at biopsy for patients with typical or atypical proliferations vs. melanoma (P < 0·01). Among samples with positive margins (n = 153), 55% (54 of 98) of typical proliferations, 77% (41 of 53) of atypical proliferations and 100% (two of two) of melanomas were re-excised. Six patients had sentinel lymph node biopsy performed, with three patients demonstrating nodes positive for melanocytic cells. Within a median follow-up of 4·1 years for the full cohort there were no related deaths.
Conclusions: Spitz tumours have strikingly benign outcomes in the paediatric population, although this study is limited by the low number of melanomas and restriction to a single paediatric institution. Aggressive management recommendations should be reconsidered for children and adolescents with banal-appearing Spitz naevi, based on the clinically indolent behaviour in this cohort.
© 2018 British Association of Dermatologists.
Conflict of interest statement
EBH discloses non-relevant conflicts of interests: UpToDate, Inc (author, contributor), Foundation Medicine, Inc (stock), and Gritstone Oncology, Inc (spouse employment, stock).
Figures
Comment in
-
The pink papules and plaques of Spitz.Br J Dermatol. 2019 Aug;181(2):235. doi: 10.1111/bjd.18160. Br J Dermatol. 2019. PMID: 31368522 No abstract available.
References
-
- R B, A B, BC B, KJ B, L C, A dlF, et al. Malignant Spitz tumour and Spitz Naevus In: DR E, D M, R S, R W, editors. WHO Classification of Skin Tumors, Fourth Edition. 4 ed: World Health Organization; 2018.
-
- Berk DR, LaBuz E, Dadras SS, Johnson DL, Swetter SM. Melanoma and melanocytic tumors of uncertain malignant potential in children, adolescents and young adults--the Stanford experience 1995–2008. Pediatric dermatology. 2010. May-Jun;27(3):244–54. PubMed PMID: 20403119. - PubMed
-
- Cerrato F, Wallins JS, Webb ML, McCarty ER, Schmidt BA, Labow BI. Outcomes in pediatric atypical spitz tumors treated without sentinel lymph node biopsy. Pediatric dermatology. 2012. Jul-Aug;29(4):448–53. PubMed PMID: 22211716. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical